Navinci Diagnostics
Pre-clinicalNavinci is a Swedish biotech company specializing in innovative in situ proximity ligation assay-based solutions for spatial proteomics.
Founded
2017
Focus
DiagnosticsOncology
About
Navinci is a Swedish biotech company specializing in innovative in situ proximity ligation assay-based solutions for spatial proteomics.
Funding History
2Total raised: $2.3M
Grant$500KVinnovaJan 15, 2022
Seed$1.8MUppsala University HoldingApr 15, 2021
Company Info
TypePrivate
Founded2017
LocationUppsala, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile